Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEXTENZA vs Prednisolone Acetate for Post-Corneal Transplant Pain and Inflammation
NCT04521140Phase 4Completed
- Start
- Oct 2020
- Primary completion
- Jan 2023
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ozurdex in ocular inflammation. Started Oct 2020; status: completed.
02
Drugs
ozurdex
03
Conditions
ocular inflammation
Beyond the preview
Go deeper on NCT04521140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04521140.